SBI Healthcare Opportunities Fund vs Nippon India Taiwan Equity Fund
Put two or three funds side by side — returns, risk, what they cost and what they actually hold. Figures are for the Direct plan, Growth option, where a fund has one.
| Fund |  SBI Healthcare Opportunities FundSectoral / Thematic Fund · Direct planNAV ₹606.67 |  Nippon India Taiwan Equity FundSectoral / Thematic Fund · Direct planNAV ₹37.7 |
|---|---|---|
| Returns | ||
| 1 year | 20.9% | 118% (best of these funds) |
| 3 yearsa year | 24.3% | 61.4% (best of these funds) |
| 5 yearsa year | 18.5% | – |
| 10 yearsa year | 14.8% | – |
| Risk | ||
| Volatilitya year | 12.9% (best of these funds) | 36.1% |
| Worst fall | −28.1% (best of these funds) | −44.8% |
| Best year | 87.1% | 279.5% (best of these funds) |
| Worst year | -18.2% (best of these funds) | -33.6% |
| Years in gain | 70% | 86% (best of these funds) |
| Cost and size | ||
| Expense ratio | 1.02% (best of these funds) | 1.24% |
| Fund size | ₹5,796 Cr | ₹1,128 Cr |
| Minimum SIP | ₹500 | – |
| Lock-in | None | None |
| Portfolio | ||
| In equity | 96.8% | – |
| In debt | 0.1% | – |
| In cash | 3.2% | – |
| Holdings | 33 | – |
Returns beyond a year are annualised. The stronger figure in each row is marked, which is not a recommendation: a fund that returned more usually took more risk to do it.
Biggest holdings
SBI Healthcare Opportunities Fund
- Sun Pharmaceutical Industries Ltd12.3%
- Divi's Laboratories Ltd8.2%
- Apollo Hospitals Enterprise Ltd4.9%
- Acutaas Chemicals Ltd4.9%
- Torrent Pharmaceuticals Ltd4.7%
As on 31 Aug 2026
Nippon India Taiwan Equity Fund
Holdings are not available for this fund yet.
Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not guarantee future returns. This page is for information only and is not a recommendation to buy or sell.